Atlas Trials

Bioequivalence Study of Rivastigmine 1.5 mg Capsules Under Fasting Conditions

Clinical trial NCT01146067 · COMPLETED

Trial details

NCT number
NCT01146067
Sponsor
Dr. Reddy's Laboratories Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2004-01-01
Primary completion
2004-02-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.